Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

Teleflex (TFX – Research Report) received a Hold rating and price target from Raymond James analyst Jayson Bedford today. The company’s ...

What Happened? Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

Principal Financial Group Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 13.1% during the fourth ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Sanctuary Advisors LLC raised its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 28.2% in the 4th ...

The upcoming report from Teleflex (TFX) is expected to reveal quarterly earnings of $3.86 per share, indicating an increase of 14.2% compared to the year-ago period. Analysts forecast revenues of ...